Guinea pigs immunized with recombinant varicella-zoster virus (VZV) glycoproteins E (gE) and I (gI) developed antigen-specific antibodies in the sera, vitreous, and conjunctival washes. Sera from immunized animals neutralized both cell-free and cell-associated VZV, and peripheral blood lymphocytes proliferated in vitro in response to recombinant gE and gI and to antigens from VZVinfected cells. Immunized guinea pigs were inoculated intravitreally with VZV, which induces chronic uveitis. VZV DNA was more rapidly cleared and infectious VZV was isolated less frequently from the retinas of animals immunized with gE and gI compared with that in controls receiving adjuvant alone. Nonetheless, cellular infiltrates in the vitreous, retina, and choroid were prevalent 21 days after VZV inoculation in both the adjuvant-alone -and gE-gI -immunized animals. Immunization with VZV gE and gI induced potent humoral and cellular responses that accelerated the clearance of VZV DNA and may neutralize virus within the eye.
Specific immunity to varicella-zoster virus (VZV) develops
in a model system. Recently, we described a guinea pig model in which VZV inoculated into the vitreous evoked a chronic during the primary infection, varicella, and confers long-term uveitis with virus detected in the iris, ciliary body, and retinal protection from further exogenous VZV reinfection. Protection pigment epithelium [14] . We have used this model system to may be lost in situations in which immunity is suppressed or determine the effect of immunization with recombinant gE and deficient or in which immunity has waned, especially in the gI on VZV-induced eye disease and clearance of infectious elderly (reviewed in [1] ). Ophthalmic involvement is rare in VZV and viral DNA from the eye and to characterize the varicella [2] but occurs frequently in herpes zoster and is potenimmune responses to these viral glycoproteins. tially sight-threatening. The ocular manifestations of herpes VZV gE and gI are glycoproteins of the virion envelope that zoster include acute and chronic forms of keratitis, uveitis, and form a non-covalently linked complex [15] [16] [17] . The biochemical retinitis [3, 4] . VZV is also associated with acute retinal necroanalysis of these envelope components has been aided by their sis, which can cause retinal detachment in both immunocompeproduction as recombinant proteins [16] [17] [18] . Recently, we puritent and immunocompromised individuals in the absence of fied gE, gI, and the gE-gI complex from the culture supernatants symptoms of zoster [5, 6] .
of insect cells infected with recombinant baculoviruses into which Immune mechanisms that protect the eye against VZV infecthe VZV gE and gI genes had been inserted [17] . tion consist of both humoral and cellular components. Some VZV gE and gI were chosen for study because they are components of the immune response to VZV may also contribcritical targets of host responses to VZV. Both humoral and ute to immunopathologic injury to the eye. Although both procellular immune responses to gE and gI are elicited following tective and pathologic immune mechanisms have been devaricella infections in humans [1] . Monoclonal antibodies to scribed for ocular infection with herpes simplex virus [7 -13] , both gE and gI neutralize VZV in vitro in a complementthese mechanisms have not been elucidated for VZV infections dependent manner [18, 19] . Compared with unimmunized aniof the eye. mals [20] , animals immunized with either VZV gE or gI were No animal species appears to be fully susceptible to VZV protected from subsequent challenge with VZV, as evidenced and, therefore, the full range of VZV disease has not been seen by a reduced induction of antibody to VZV open-reading frame 62 (ORF 62) protein, which was used as a marker of viral replication. JID 1998;178 (August) Immunogenicity of VZV gE and gI per minute (cpm) in antigen-stimulated wells to the mean cpm in
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control wells.
Ocular VZV infections and sample preparations. Recombinant Recombinant proteins. Recombinant VZV gE and gI and the gE-gI complex were expressed in insect cells and purified in solu-VZV strain Oka expressing b-galactosidase, termed ROka-LacZ [14], was passaged 10 times in guinea pig embryo fibroblasts. ble forms by metal affinity chromatography, as previously described [17] . Each purified protein was dialyzed against PBS and Guinea pigs were inoculated bilaterally by the intravitreal route with guinea pig fibroblasts containing 200 pfu of VZV in 10 mL. stored at 070ЊC until use.
Immunization of guinea pigs. Female Hartley guinea pigs (5 At various times after infection, animals were sacrificed and eyes were harvested for virus isolation, PCR analysis, and histology. weeks old) were immunized with either a mixture of purified recombinant gE and gI (25 mg each) or the recombinant gE-gI comFor virus isolation and PCR, each eye was cut in half sagittally, frozen, and stored at 070ЊC. To isolate retinas, the eyes were plex (50 mg). Purified protein solutions (0.25 mL) were injected intramuscularly with 0.25 mL of complete Freund's adjuvant at thawed, and the lens and vitreous were removed. The retinal preparations, consisting mainly of the neural retina and retinal pigment the first injection followed with incomplete Freund's adjuvant at the second and third injections at 2-week intervals. Control animals epithelial layer and ciliary bodies, were isolated for further study. For virus isolation, retinas were inoculated onto MRC-5 cells. received 0.25 mL of PBS and an equal amount of adjuvant.
ELISA. Purified recombinant VZV glycoproteins (125 ng/ After 7 days, plaques were counted by light microscopy. VZV plaques were confirmed by X-gal staining for the b-galactosidase well) were coated onto 96-well plates (Immulon; Dynatech Laboratories, Chantilly, VA) overnight. After blocking with 5% dry milk enzyme expressed by the challenge virus. DNA for PCR assays was extracted from the retinas (Puregene in PBS, serially diluted pre-or postimmune sera were added to the plate in duplicate and incubated for 1 h. The bound antibodies DNA isolation kit; Gentra Systems, Minneapolis), and the concentration of the DNA was determined by spectrophotometry. were detected by horseradish peroxidase-labeled anti-guinea pig IgG antibody (Sigma, St. Louis) and tetramethylbenzidine subVitreous humor was obtained for the detection of antibodies. To avoid contamination with serum, frozen vitreous bodies were strate kit (Kirkegaard & Perry Laboratories, Gaithersburg, MD), and optical densities were measured at 450 nm. The serum titers removed from eyes before thawing. Isolated vitreous humor was then used in an ELISA. were determined as the highest dilution in which an optical density value exceeded 0.2.
For determination of cellular infiltration, whole eyes were fixed in 10% formalin and stained with hematoxylin-eosin. The number For the detection of antibodies in conjunctival washes, a cottontipped swab was rolled over the upper and lower conjunctival culof inflammatory cells in the vitreous was determined from stained sections. de-sac and retained in the nasal fornix for 10 s. Conjunctival fluid was eluted from the swabs in 0.5 mL of PBS, and serial dilutions Quantitative DNA PCR. VZV DNA was quantitated by two methods, using a phosphorescent imager and by ''real-time'' fluwere then tested in the gE and gI ELISAs.
Neutralization assays. Neutralizing antibody titers were deterorogenic assay. Phosphorescent imager. PCR was done using primers specific mined by plaque-reduction assay on MRC-5 cells. Cell-free VZV (clinical grade Oka strain varicella vaccine, a gift from Merck, for the sequence encoding VZV glycoprotein B (gB), as previously described [21] . Briefly, 1 mg of extracted DNA in a total volume West Point, PA) was incubated for 1 h at 37ЊC with serially diluted sera in the presence of 10% guinea pig complement (Life Technolof 100 mL was amplified for 35 cycles at 95ЊC for 1 min, 60ЊC for 30 s, and 72ЊC for 1 min, with a final 7-min extension interval. ogies Gibco BRL, Gaithersburg, MD) and inoculated on MRC-5 cells. After 7 days, cells were stained with crystal violet and Each experiment contained at least 2 negative controls containing DNA from mock-infected eyes. Amplified products were separated plaques were counted. Neutralizing titers were defined as the minimal dilution in which the plaque number was reduced to 50% of on a 2% agarose gel, transferred onto a nylon membrane, and hybridized with a 32 P-labeled oligonucleotide probe located interthe mean value of the control.
For neutralization of cell-associated virus, VZV-infected guinea nal to the amplified DNA segment. The membrane was washed and exposed to X-OMAT film (Eastman Kodak Company, Rochespig embryo fibroblasts were incubated for 1 h at 37ЊC with serially diluted postimmune serum in the presence of the complement and ter, NY) for 16 h. The same membrane was used for the quantitation. To estimate the copy number of VZV, the radioactivity of were inoculated onto MRC-5 cells. After 5 days, cells were stained with crystal violet and plaques were counted.
the probe hybridized to the amplified product was quantitated by laser imaging of phosphorescent storage plates (PhosphorImager; Lymphocyte proliferation assay. Blood was obtained from guinea pigs by cardiac puncture, and peripheral blood mononuclear Molecular Dynamics, Sunnyvale, CA). A plasmid containing the complete gB gene in pUC19 (pUC19-VZVgB; gift of Liyange cells (PBMC) were separated with Ficoll-Paque (Pharmacia Biotechnology, Piscataway, NJ). PBMC were cultured at 2 1 10 5 Perera, NIH, Bethesda, MD) was used as a positive control. A standard curve was constructed based on the amount of product cells/well (0.2 mL total volume) in RPMI 1640 with 10% guinea pig serum containing 30 mM HEPES and 30 mM 2-mercaptoethaobtained from serially diluted PUC19-VZVgB ( figure 1A ). Each sample of the standard curve also contained 1 mg of genomic DNA nol. The cells were stimulated with 10 mg of purified gE or gI or with VZV antigens [20] consisting of sonicated VZV-infected derived from uninfected guinea pig eyes. Although controls containing ú10 3 copies of DNA were beyond guinea pig fibroblasts. In each assay, PBS and sonicated uninfected guinea pig fibroblasts were used as negative controls. After 5 the linear range, this method was quite sensitive and could detect two copies of plasmid DNA per sample. The amount of product days, cells were pulsed with 1 mCi/well 
Real-time quantitative PCR of VZV DNA by fluorogenic 5-3
at a minimum of 20 copies and extending through 10 6 copies of gB plasmid. nuclease assay. Primers for this PCR system were also selected from the gene encoding gB. The upstream and downstream primer Statistical analysis. The software package JMP (SAS Institute, Cary, NC) was used for data analysis. Comparison of means was sequences were 5-GATGGTGCATACAGAGAACATTCC-3 and 5-CCGTTAAATGAGGCGTGACTAA-3, respectively. Amdone using the Student's t test or the Wilcoxon rank sum test. plification with these primers yielded a 139-bp product. A fluorogenic probe (5-ATTACTGGAACCTGCAGCGCGGA-3), the sequence of which was located between the above primers, was Results synthesized by PE Applied Biosystems (Foster City, CA). The probe was derivatized with a fluorescent reporter dye (6-carboxyRecombinant gE and gI induce high levels of glycoproteinfluorescein, FAM) at its 5 end and a quencher dye (6-carboxyspecific antibodies. Guinea pigs were immunized three times tetramethyl-rhodamine, TAMRA) at the 3 end. PCR reactions with either a mixture of purified recombinant gE and gI or the were performed using the TaqMan PCR kit (PE Applied Biosyspurified recombinant gE-gI complex. Control animals received tems). The 50-mL PCR mixture contained 10 mM Tris (pH 8.3), adjuvant alone. One week after the last immunization, sera 50 mM KCl, 10 mM EDTA, 3.5 mM MgCl 2, 200 mM dUTP, dATP, were obtained from each animal and tested using an ELISA. dCTP, dGTP, 0.3 mM each primer and the fluorogenic probe, 0. 025 High titers of antibodies against gE and gI (ú1:32,000) were U/mL AmpliTaq Gold, 0.01 U/mL AmpErase UNG, and 0.5 mg template DNA. Following a reaction of AmpErase UNG for 2 min detected in the sera of all animals immunized with a mixture at 50ЊC and activation of AmpliTaq Gold for 10 min at 95ЊC, 50 of gE and gI or with the gE-gI complex but not in the sera of cycles of 15 s at 95ЊC, and 1 min at 60ЊC were carried out using control animals or in preimmune sera ( figure 2A ). with the mixture of gE and gI or with the gE-gI complex, as compared with the control animals ( figure 3 ). These data indicate that recombinant gE and gI proteins, PBMC were obtained from animals 3 weeks after the final either in a mixture or covalently complexed form, induced immunization and were tested for antigen-specific lymphocyte potent humoral immune responses in guinea pigs. Because the proliferation. Lymphocytes from gE-gI -immunized animals antibody responses to the gE-gI mixture and the gE-gI complex proliferated in response to purified recombinant gE and gI and were comparable, only the gE-gI mixture was used for further also to antigens obtained from VZV-infected cells (table 1) . experiments.
As expected, lymphocytes from control animals did not respond Induction of lymphocyte proliferation responses to gE to any of these antigens. These results indicate that the recombiand gI. Animals immunized with the mixture of gE and gI nant gE and gI can induce cellular immunity in guinea pigs. were tested for cell-mediated immunity (CMI) to VZV and
Persistence of infectious VZV in the eye. To determine compared with control animals that received adjuvant alone.
whether immunization with gE and gI can enhance the clearance of VZV in vivo, both immunized and control (adjuvantalone) guinea pigs were challenged with VZV. Animals (28/ group) were inoculated intravitreally with 200 pfu of cell-associated VZV 4 weeks after the final immunization. At 4 h after inoculation, 4 animals from each group were sacrificed, and their eyes were harvested to test for infectious VZV. In the gE-gI -immunized group, VZV was isolated from only 1 of 4 animals, and this animal had the lowest CMI and the lowest titer of anti -gE and anti -gI antibodies in the vitreous body (animal no. 4, table 2). In contrast, VZV was isolated from 3 of 4 animals in the adjuvant-alone group. These data suggest that nearly all of the VZV inoculum had been neutralized within 4 h after the challenge in immunized animals. We also tested for infectious virus in the eyes of 4 immunized and 4 control guinea pigs at 3 days after VZV inoculation. Again, we could isolate VZV from only 1 of 4 immunized but 3 of 4 control guinea pigs. Quantitation of VZV DNA in challenged guinea pigs. To quantitate the amount of VZV DNA in guinea pig retinas, we used two independent PCR-based methods. One uses traditional PCR assay coupled with Southern blot hybridization, which is then quantitated from a phosphorescent storage screen. The other method uses the recently developed Taq polymerase 3 -5 nuclease assay, which is analyzed via fluorogenic probes coupled with real-time fluorescence detection. DNA was extracted from the retinas of eyes harvested at 4 h and at 3 days after infection and analyzed with both quantitative PCR systems. For each animal, the copy numbers of VZV DNA NOTE. CMI (cell-mediated immunity) was determined by lymphocyte proliferation assay and shown as stimulation index. PCR, polymerase chain reaction.
* Reciprocal antibody titer.
In contrast to these results, there was less VZV DNA 3 days 21 after challenge, 20 animals in each group were sacrificed, and the mean numbers of inflammatory cells in the retina and after infection in the immunized group than in the control animals. Quantitative PCR assay by Southern blot showed that vitreous were counted in a masked fashion. Uninfected animals had no detectable infiltrating cells regardless of the immunogen the copy numbers of VZV DNA in the retinas were 73% lower in the gE-gI -immunized group than in the control group (figure used. In contrast, infected animals had large increases in infiltrating cells. VZV-infected guinea pigs that had been given 4, table 3). These differences were statistically significant at P õ .05 when compared using the Wilcoxon rank sum test. Beadjuvant alone or gE-gI in adjuvant had significant increases in infiltrating cells compared with infected animals given no cause the sensitivity of the fluorogenic PCR in our setting was lower than that of the PCR -Southern blot system (figure 1), adjuvant (P Å .03 and .08, respectively, Student's t test; table 4). Infected animals administered gE-gI in adjuvant showed a we could not detect VZV DNA in most retinas at day 3 by the fluorogenic PCR system (table 3) . Quantitation by Southern slightly greater but nonsignificant number of infiltrating cells than the infected recipients of adjuvant alone. blot was repeated using retinal DNA obtained from the opposite eye of each animal, and the results were similar: The mean copy numbers of the immunized group were again approxiDiscussion mately one-fourth that of the control group. Taken together, these results suggest that immunization with recombinant
The guinea pig intravitreal model of VZV infection was developed with the goal of using it to study host defense factors gE-gI led to faster clearance of both infectious VZV and VZV DNA from the guinea pig retinas.
that control VZV spread, both within and beyond the eye, as well as factors that contribute to VZV disease pathogenesis in Uveitis is not prevented by vaccination. Because we had shown that VZV inoculated into the posterior chamber of the the eye. To further explore this model, we infected guinea pigs that had previously been vaccinated with recombinant VZV guinea pig eye causes chronic uveitis [14], we wanted to determine if immunization with the recombinant gE and gI could glycoproteins. VZV gE, the most abundant VZV envelope glycoprotein, has been proposed as a subunit vaccine [22, 23] . prevent or otherwise alter the inflammatory response. At day VZV gI forms a heterodimer with gE [17] and is necessary for tients are at greater risk for cutaneous and visceral spread of VZV, which results in significant morbidity following either correct biosynthesis and subcellular localization of gE [16, 24, 25] . Therefore, we vaccinated animals with gE and gI, an initial or a recurrent VZV infection. In this respect, immunization of guinea pigs with recombinant gE and gI elicited quantitated humoral and cellular immune responses to this vaccine, and assayed their impact on subsequent intravitreal chalsubstantial levels of VZV-specific cellular immunity as assayed by proliferative responses to the recombinant proteins and to lenge with VZV.
Our results show that immunization with recombinant VZV infected cell sonicates. gE and gI produced high titers of serum antibodies directed
The effect of specific immunity on clearance of infectious to these VZV envelope components. These serum antibodies VZV from the guinea pig eye was apparent in the present neutralized in vitro both the cell-associated and cell-free forms experiments, even at the earliest time points. We found that of VZV. Whereas humoral responses to VZV do not protect VZV could not be isolated from most gE-gI -immunized aniagainst established varicella [26] , antibodies are important in mals within 4 h of inoculation, suggesting that antibodies or modifying the early stages of VZV infection [27, 28] . In the cytotoxic cells in the eyes of immunized animals quickly supcurrent study, antibodies against both VZV gE and gI were pressed the initial infection of VZV. VZV DNA levels meafound in the vitreous and tear fluid of immunized animals. sured 4 h after inoculation, however, were not yet reduced Thus, in the immunized guinea pig, the specific humoral rein immunized animals compared with adjuvant-alone control sponse to gE and gI is positioned to limit the spread of VZV animals. Therefore, while the infectivity may have been neufrom the initial site of infection. Since the immunizations with tralized quickly in the eye, the VZV DNA had not yet been recombinant VZV glycoproteins were given intramuscularly, cleared. At 3 days, VZV DNA was significantly reduced and the presence of these antibodies in the vitreous before challenge infectious virus was recovered less often in the gE-gI -vacciwith virus is likely to have resulted from leakage into the eye nated guinea pigs than in the control animals. The levels of from the systemic circulation.
VZV DNA observed in the control animals on day 3, however, Cellular immunity to VZV is essential to the clearance of were also lower than those observed in this group at 4 h after infected cells in varicella and zoster [1] . Immunodeficient painoculation. Thus, VZV DNA was also being cleared, albeit more slowly, in the absence of immunization. This indicates that intravitreal inoculation with VZV in these experiments did 
